Investing in ATOM can be worthwhile for aggressive growth investors seeking exposure to cutting-edge semiconductor innovations, but it carries substantial financial risk. Because the company is still scaling its commercial licensing business model and has historically operated at a net loss, investors must be prepared for extreme share price volatility, potential equity dilution, and lengthy waits before breakthrough commercial adoption reflects positively on the company's fundamental financial statements.